562 related articles for article (PubMed ID: 18000800)
1. Inhibition of platelet function: does it offer a chance of better cancer progression control?
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
[TBL] [Abstract][Full Text] [Related]
2. Platelets and angiogenesis in malignancy.
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2004 Feb; 30(1):95-108. PubMed ID: 15034801
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
Rak J; Klement P; Yu J
Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
[TBL] [Abstract][Full Text] [Related]
4. Platelets and cancer: implications for antiangiogenic therapy.
Trikha M; Nakada MT
Semin Thromb Hemost; 2002 Feb; 28(1):39-44. PubMed ID: 11885024
[TBL] [Abstract][Full Text] [Related]
5. The role of hemostatic system inhibitors in malignancy.
Wojtukiewicz MZ; Sierko E; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):621-42. PubMed ID: 18000789
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the hemostatic system to angiogenesis in cancer.
Wojtukiewicz MZ; Sierko E; Rak J
Semin Thromb Hemost; 2004 Feb; 30(1):5-20. PubMed ID: 15034794
[TBL] [Abstract][Full Text] [Related]
7. The role of platelet activation in tumor metastasis.
Borsig L
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1247-55. PubMed ID: 18699763
[TBL] [Abstract][Full Text] [Related]
8. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
Falanga A; Marchetti M; Vignoli A; Balducci D
Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
Rak J; Milsom C; May L; Klement P; Yu J
Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
[TBL] [Abstract][Full Text] [Related]
10. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
Ojiro M
Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
[No Abstract] [Full Text] [Related]
11. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
12. [Cancer, hemostasis and coaguloactive drugs].
Nadiradze ISh
Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281
[No Abstract] [Full Text] [Related]
13. Heparin in tumor progression and metastatic dissemination.
Falanga A; Marchetti M
Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
[TBL] [Abstract][Full Text] [Related]
14. The genetics of antiplatelet drug resistance.
Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
16. [A new look at platelets and microparticles, including their role in haemostatic disorders and progression of neoplastic disease].
Łuksza E; Mantur M
Pol Merkur Lekarski; 2009 Dec; 27(162):491-5. PubMed ID: 20120715
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
18. [Development and dissemination of malignant tumors and hemostasis].
Kher A; Hilgard P
Pathol Biol (Paris); 1982 Dec; 30(10):861-7. PubMed ID: 6760066
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic abnormalities associated with cancer and its therapy.
Glassman AB
Ann Clin Lab Sci; 1997; 27(6):391-5. PubMed ID: 9433535
[TBL] [Abstract][Full Text] [Related]
20. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
